The Pharmaceutical Price Regulation Scheme (PPRS) came into force in January 2014, and involved the UK industry effectively ... second part of Sarah Rickwood's overview of the UK market will ...

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the Association of the British Pharmaceutical Industry (ABPI). As one of the ...

We asked Tom Delahoyde, managing director at Chiesi UK & Republic of Ireland, his thoughts on the industry’s role in achieving a sustainable future. Why is the pharmaceutical industry so ...

Danish company Novo Nordisk's membership in a UK pharmaceutical industry body has been restored after a two-year suspension ...

The number of deals in the UK healthcare mergers & acquisition ... As in previous years, pharma and life sciences were the most active sectors, accounting for 35% of the deal volume. Analysis by the ...